Revance Therapeutics (RVNC)

$3.65 +0.01 (0.27%)
Market Cap 381.02M
Revenue (ttm) 234.04M
Net Income (ttm) -323.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -138.43%
Debt to Equity Ratio -0.13
Volume 4,123,100
Avg Vol 3,110,214
Day's Range N/A - N/A
Shares Out 104.39M
Stochastic %K 47%
Beta 0.90
Analysts Sell
Price Target $8.00
11thestate
11thestate Apr. 27 at 4:05 PM
$RVNC — Updates for the Revance Therapeutics investor settlement The settlement has just received preliminary approval, and you can already submit a claim to get payment. 📌 What happened? Revance allegedly misled investors about the strength and sustainability of its Teoxane partnership and overall sales performance. The issue came to light when a breach notice, stricter contract terms, and financial concerns were disclosed, leading to a reduced acquisition offer and significant pressure on the company’s outlook. ❓ Who qualifies? Buyers of $RVNC between February 29, 2024, and February 6, 2025, inclusive. ➡️ Apply now: https://11th.com/cases/revance-investor-settlement
1 · Reply
BNBComedian
BNBComedian Jul. 23 at 2:28 AM
$RVNC this was a sure thing at $25
0 · Reply
Thebiggerone
Thebiggerone Feb. 14 at 1:10 AM
$RVNC penny land inbound
0 · Reply
TheMAGATrader
TheMAGATrader Feb. 13 at 9:52 PM
$RVNC Hahahahahahah...
0 · Reply
Estimize
Estimize Feb. 10 at 1:27 PM
Wall St is expecting -0.30 EPS for $RVNC Q1 [Reporting 05/08 AMC] http://www.estimize.com/intro/rvnc?chart=historical&metric_name=eps&utm_c
0 · Reply
wrynot
wrynot Feb. 6 at 3:02 PM
$RVNC I’m going to have a $TELL 2.0 delisting ceremony. I hope Foley has to sell his house like Souki.
2 · Reply
AlertsAndNews
AlertsAndNews Feb. 6 at 1:42 PM
$RVNC Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics Currently t-12 halted
0 · Reply
HellenJune
HellenJune Feb. 6 at 1:07 PM
https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-shareholders-of-revance-therapeutics-incrvnc-of-a-class-action-lawsuit-and-an-upcoming-deadline-302369534.html $RVNC
0 · Reply
Mergerbrief
Mergerbrief Feb. 4 at 1:23 PM
$RVNC / Crown Labs - Tender Offer Expires Today MergerBrief.com Merger Tracking
0 · Reply
RainyDayFund
RainyDayFund Feb. 4 at 12:20 AM
$RVNC So I guess we have no choice and have to take their measly $3.65 per share?
1 · Reply
Latest News on RVNC
Rosen Law Firm Urges Revance Therapeutics, Inc. (NASDAQ: RVNC) Stockholders to Contact the Firm for Information About Their Rights

Feb 28, 2025, 5:54 PM EST - 1 year ago

Rosen Law Firm Urges Revance Therapeutics, Inc. (NASDAQ: RVNC) Stockholders to Contact the Firm for Information About Their Rights

RVNC STOCK NEWS: Robbins LLP Reminds Revance Therapeutics, Inc. Investors of the Pending Lead Plaintiff Deadline – March 4, 2025

Feb 18, 2025, 8:31 PM EST - 1 year ago

RVNC STOCK NEWS: Robbins LLP Reminds Revance Therapeutics, Inc. Investors of the Pending Lead Plaintiff Deadline – March 4, 2025

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Feb 13, 2025, 5:45 AM EST - 1 year ago

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights – RVNC

Feb 12, 2025, 12:48 PM EST - 1 year ago

Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights – RVNC

Crown Laboratories Completes Acquisition of Revance Therapeutics

Feb 7, 2025, 3:46 PM EST - 1 year ago

Crown Laboratories Completes Acquisition of Revance Therapeutics

Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics

Feb 6, 2025, 8:39 AM EST - 1 year ago

Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics

Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer

Feb 5, 2025, 8:00 AM EST - 1 year ago

Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer

Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline

Jan 31, 2025, 7:30 AM EST - 1 year ago

Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline

Shareholders of Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Jan 23, 2025, 5:45 AM EST - 1 year ago

Shareholders of Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC

Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer

Jan 21, 2025, 8:00 AM EST - 1 year ago

Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer

Crown Laboratories Extension of Tender Offer to Acquire Revance Therapeutics, Inc.

Jan 13, 2025, 8:30 AM EST - 1 year ago

Crown Laboratories Extension of Tender Offer to Acquire Revance Therapeutics, Inc.

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 4, 2025 in Revance Lawsuit - RVNC

Jan 9, 2025, 5:45 AM EST - 1 year ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 4, 2025 in Revance Lawsuit - RVNC

Deadline Approaching: Revance Therapeutics, Inc. (RVNC) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Jan 8, 2025, 12:00 PM EST - 1 year ago

Deadline Approaching: Revance Therapeutics, Inc. (RVNC) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Teoxane SA Announces Superior Proposal to Acquire Revance Therapeutics for $3.60 per Share in Cash

Jan 6, 2025, 9:00 AM EST - 1 year ago

Teoxane SA Announces Superior Proposal to Acquire Revance Therapeutics for $3.60 per Share in Cash

REVANCE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Revance Therapeutics, Inc. - RVNC

Dec 17, 2024, 2:31 PM EST - 1 year ago

REVANCE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Revance Therapeutics, Inc. - RVNC

11thestate
11thestate Apr. 27 at 4:05 PM
$RVNC — Updates for the Revance Therapeutics investor settlement The settlement has just received preliminary approval, and you can already submit a claim to get payment. 📌 What happened? Revance allegedly misled investors about the strength and sustainability of its Teoxane partnership and overall sales performance. The issue came to light when a breach notice, stricter contract terms, and financial concerns were disclosed, leading to a reduced acquisition offer and significant pressure on the company’s outlook. ❓ Who qualifies? Buyers of $RVNC between February 29, 2024, and February 6, 2025, inclusive. ➡️ Apply now: https://11th.com/cases/revance-investor-settlement
1 · Reply
BNBComedian
BNBComedian Jul. 23 at 2:28 AM
$RVNC this was a sure thing at $25
0 · Reply
Thebiggerone
Thebiggerone Feb. 14 at 1:10 AM
$RVNC penny land inbound
0 · Reply
TheMAGATrader
TheMAGATrader Feb. 13 at 9:52 PM
$RVNC Hahahahahahah...
0 · Reply
Estimize
Estimize Feb. 10 at 1:27 PM
Wall St is expecting -0.30 EPS for $RVNC Q1 [Reporting 05/08 AMC] http://www.estimize.com/intro/rvnc?chart=historical&metric_name=eps&utm_c
0 · Reply
wrynot
wrynot Feb. 6 at 3:02 PM
$RVNC I’m going to have a $TELL 2.0 delisting ceremony. I hope Foley has to sell his house like Souki.
2 · Reply
AlertsAndNews
AlertsAndNews Feb. 6 at 1:42 PM
$RVNC Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics Currently t-12 halted
0 · Reply
HellenJune
HellenJune Feb. 6 at 1:07 PM
https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-shareholders-of-revance-therapeutics-incrvnc-of-a-class-action-lawsuit-and-an-upcoming-deadline-302369534.html $RVNC
0 · Reply
Mergerbrief
Mergerbrief Feb. 4 at 1:23 PM
$RVNC / Crown Labs - Tender Offer Expires Today MergerBrief.com Merger Tracking
0 · Reply
RainyDayFund
RainyDayFund Feb. 4 at 12:20 AM
$RVNC So I guess we have no choice and have to take their measly $3.65 per share?
1 · Reply
valueforme
valueforme Feb. 1 at 10:52 PM
$RVNC This never ending merger is a good reminder that selling right after merger announcement is the safest way to react
0 · Reply
swingingtech
swingingtech Jan. 24 at 12:51 AM
$RVNC https://wallstreetwaves.com/revance-therapeutics-investors-can-now-take-the-lead-in-securities-fraud-lawsuit-following-losses/
1 · Reply
Miok
Miok Jan. 21 at 4:58 PM
$DRMA $RVNC Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer
0 · Reply
RonIsWrong
RonIsWrong Jan. 21 at 2:04 PM
$RVNC Crown Laboratories hikes offer price for Revance to $3.65/share, extends existing tender offer
0 · Reply
ganduseph
ganduseph Jan. 17 at 2:10 PM
$RVNC Crown offering $3.65 now. Interesting.
1 · Reply
TheMAGATrader
TheMAGATrader Jan. 14 at 8:38 PM
$RVNC wow up 1 cent! Watch out everyone. Shit company shit daxxify and shit management!
0 · Reply
BugHunti
BugHunti Jan. 13 at 7:47 PM
$RVNC lol
1 · Reply
BPharmCatalyst
BPharmCatalyst Jan. 6 at 9:50 PM
$RENB has entered into a binding LOI to acquire $POAI.DL0326 in an all-stock transaction. See More Biotech Updates👇 https://www.biopharmcatalyst.com/news/2025/predictive-poai-acquired-by-renovaro-renb $AEON $HYPD $CERO $SPRC $BTAI $SLRN $RVNC $NAOV $BCTX $NARI
0 · Reply